After studying the relationship of this molecule with this disease, the experts believe that cardiotrophin 1 is useful for preventing or controlling the damaging effects on the heart suffered by patients with this disease. In Spain, there are four million patients with this illness, a number that supposes fifty percent of the eight million patients with high blood pressure.
The research on this cardiovascular illness was shared today during the course of the International Congress Frontiers in Transnational Research of Cardiovascular Diseases, held in the CIMA, and in which dozens of Spanish, Germans, British and Dutch scientists participated.
Currently, these types of illnesses are the number one cause of doctor’s visits, hospitalization and death worldwide. As it is foreseen that their frequency will increase in the next decades, experts propose the soonest possible application of the latest biomedical and biotechnological advances for the diagnosis, prevention and treatment of these pathologies.
Stroke and Atrial Fibrillation Prevention
Cardiotrophin 1 as it intervenes in the earliest phases of hypertensive cardiopathy, if we act on it we can prevent complications such as cardiac insufficiency, atrial fibrillation, strokes and even patient death.
The speakers also touched on aspects of high blood pressure, which affects more than 25% of the adult population. For example, they revised the advances in the diagnosis and treatment of lesions that this pathology produces in the heart, the brain and the kidneys, saying that is one of the primary causes of problems such as cardiac insufficiency, vascular dementia and kidney failure.
In addition, they studied the harmful impact of diabetes and obesity on the heart and the arteries. In this sense, they presented pharmaceutical advances that can lead to a revolution in the current therapy used. Finally, they spoke of atherosclerosis (arterial hardening), the most common illness and with the worst consequences. They also analyzed the use of biomarkers for early detection of future strokes (whether cerebral or heart attacks) and cellular therapy in order to minimize its consequences.
Irati Kortabitarte | alfa
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy